Hain Celestial misses by $0.01, reports revs in-line; guides FY18 in-line; explores divestiture of Hain Pure Protein (36.36)
- Reports Q2 (Dec) earnings of $0.41 per share, excluding non-recurring items, $0.01 worse than the Capital IQ Consensus of $0.42; revenues rose 4.8% year/year to $775.2 mln vs the $774.5 mln Capital IQ Consensus, or 2% on a constant currency basis, primarily reflecting mid-single digit net sales increases from United Kingdom, Canada and Europe and Hain Pure Protein operating segments, partially offset by a low single digit decrease from the United States segment. Net sales for Hain Celestial United States decreased 3% over the prior year period to $270.3 million. Net sales for Hain Celestial United Kingdom increased 12% to $238.2 million.
- Co issues in-line guidance for FY18, sees EPS of $1.64-1.75 including $0.08-0.09 benefit from tax reform, from $1.63-1.80, excluding non-recurring items, vs. $1.66 Capital IQ Consensus; reaffirms FY18 revs of $2.967-3.036 bln vs. $2.99 bln Capital IQ Consensus Estimate.
- Co announced it is exploring the divestiture of its Hain Pure Protein. Net sales for Hain Pure Protein increased 4% to $159.0 million over the prior year period. business.